Cargando…

Interventions Increase Vaccination Rates in Inflammatory Bowel Disease and Rheumatoid Arthritis: A Systematic Review and Meta-Analysis

BACKGROUND: Patients with immune-mediated conditions such as IBD and RA are at risk for vaccine-preventable infections. Despite guideline recommendations, prior studies have shown suboptimal vaccination rates. AIM: We conducted a systematic review and meta-analysis to compare the different intervent...

Descripción completa

Detalles Bibliográficos
Autores principales:	Patel, Jalpa, Noureldin, Mohamed, Fakhouri, Dina, Farraye, Francis A., Kovar-Gough, Iris, Warren, Bradley, Waljee, Akbar K., Piper, Marc S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10079156/ https://www.ncbi.nlm.nih.gov/pubmed/37024741 http://dx.doi.org/10.1007/s10620-023-07903-7

Ejemplares similares

On-site Availability Improves Vaccination Rates in Patients With Inflammatory Bowel Disease
por: Hashash, Jana G, et al.
Publicado: (2021)

Overuse of glucocorticoids in rheumatoid arthritis: a national survey of primary care physicians
por: Wallace, Beth I, et al.
Publicado: (2018)

Increased risk for inflammatory bowel disease in congenital hypothyroidism supports the existence of a shared susceptibility factor
por: Grasberger, Helmut, et al.
Publicado: (2018)

Health Maintenance for Adult Patients with Inflammatory Bowel Disease
por: Hashash, Jana G., et al.
Publicado: (2021)

Roles of Clinical Pharmacists in Caring for Patients With Inflammatory Bowel Disease During COVID-19
por: Bhat, Shubha, et al.
Publicado: (2021)

Use of Standardized Inflammatory Bowel Disease Endoscopy Scores in Clinical Practice
por: Gaidos, Jill K J, et al.
Publicado: (2023)

Major depressive disorders in patients with inflammatory bowel disease and rheumatoid arthritis
por: Haider, Maryam Bilal, et al.
Publicado: (2023)

Efficacy of Paxlovid and Lagevrio for COVID-19 Infection in Patients With Inflammatory Bowel Disease: A Propensity-Matched Study
por: Hashash, Jana G., et al.
Publicado: (2023)

Accuracy of Self-Reported Vaccination Status in a Cohort of Patients with Inflammatory Bowel Disease
por: Smith, Ryan, et al.
Publicado: (2020)

Phenolic Compounds Impact on Rheumatoid Arthritis, Inflammatory Bowel Disease and Microbiota Modulation
por: Direito, Rosa, et al.
Publicado: (2021)

New Rheumatoid Arthritis Treatments for ‘Old’ Patients: Results of a Systematic Review
por: Caporali, Roberto, et al.
Publicado: (2020)

Tixagevimab and Cilgavimab (Evusheld) as Pre-exposure Prophylaxis for COVID-19 in Patients With Inflammatory Bowel Disease: A Propensity Matched Cohort Study
por: Desai, Aakash, et al.
Publicado: (2023)

Treatment Patterns and Pharmacoutilization in Patients Affected by Rheumatoid Arthritis in Italian Settings
por: Perrone, Valentina, et al.
Publicado: (2021)

Media Consumption and Creation in Attitudes Toward and Knowledge of Inflammatory Bowel Disease: Web-Based Survey
por: Groshek, Jacob, et al.
Publicado: (2017)

Cost-effectiveness analysis of baricitinib versus adalimumab for the treatment of moderate-to-severe rheumatoid arthritis in Spain
por: Schlueter, Max, et al.
Publicado: (2019)

Arterial stiffness and ankle brachial index in patients with rheumatoid arthritis and inflammatory bowel disease
por: Ozturk, Kadir
Publicado: (2016)

The Immunogenicity of the Influenza, Pneumococcal, and Hepatitis B Vaccines in Patients With Inflammatory Bowel Disease Treated With Vedolizumab
por: Harrington, Jill E, et al.
Publicado: (2020)

CXCL10 as a shared specific marker in rheumatoid arthritis and inflammatory bowel disease and a clue involved in the mechanism of intestinal flora in rheumatoid arthritis
por: Guan, Yin, et al.
Publicado: (2023)

A Network Meta-Analysis to Compare Effectiveness of Baricitinib and Other Treatments in Rheumatoid Arthritis Patients with Inadequate Response to Methotrexate
por: Fakhouri, Walid, et al.
Publicado: (2020)

Letter to the Editor Regarding Comparative Efficacy of JAK Inhibitors for Moderate-to-Severe Rheumatoid Arthritis: A Network Meta-Analysis
por: Fakhouri, Walid, et al.
Publicado: (2021)

Interleukin-7 deficiency in rheumatoid arthritis
por: Leonard, Warren J
Publicado: (2005)

CT utilization abruptly increases at age 18 among patients with inflammatory bowel diseases in the hospital
por: Govani, Shail M., et al.
Publicado: (2018)

Standardizing shared vaccination responsibilities among specialists to improve vaccination rates of immunosuppressed patients
por: Bhat, Shubha, et al.
Publicado: (2021)

Replicating prediction algorithms for hospitalization and corticosteroid use in patients with inflammatory bowel disease
por: Gan, Ryan W., et al.
Publicado: (2021)

Rituximab for Rheumatoid Arthritis
por: Cohen, Marc D., et al.
Publicado: (2015)

Patterns of care for inflammatory bowel disease in China during the COVID-19 pandemic
por: Chen, Yan, et al.
Publicado: (2020)

Effect of vitamin D on the recurrence rate of rheumatoid arthritis
por: YANG, JUNXIA, et al.
Publicado: (2015)

Malignancy rates in patients with rheumatoid arthritis treated with tocilizumab
por: Rubbert-Roth, Andrea, et al.
Publicado: (2016)

Prevalence Rate of Hearing Loss in Patients with Rheumatoid Arthritis
por: Almasi, Simin, et al.
Publicado: (2023)

Association of serum IgG4 and disease outcomes in patients with inflammatory bowel disease
por: Chase, R. Christopher, et al.
Publicado: (2023)

An Unusual Cause of Large Bowel Obstruction in a Patient With Ulcerative Colitis
por: Moktan, Varun P., et al.
Publicado: (2021)

Therapeutic effect of the immunomodulatory drug lenalidomide, but not pomalidomide, in experimental models of rheumatoid arthritis and inflammatory bowel disease
por: Lopez-Millan, Belen, et al.
Publicado: (2017)

The risk of rheumatoid arthritis among patients with inflammatory bowel disease: a systematic review and meta-analysis
por: Chen, Yi, et al.
Publicado: (2020)

Real-World Analysis of Therapeutic Patterns in Patients Affected by Rheumatoid Arthritis in Italy: A Focus on Baricitinib
por: Perrone, Valentina, et al.
Publicado: (2020)

Management of Inflammatory Bowel Disease Using E-health Technologies: A Systematic Review and Meta-Analysis
por: Kuriakose Kuzhiyanjal, Anish J, et al.
Publicado: (2023)

Benefits and Challenges of Treat-to-Target in Inflammatory Bowel Disease
por: West, Jack, et al.
Publicado: (2023)

Equivalent Cellular and Humoral Immunity to Varicella Zoster Virus in Patients With Inflammatory Bowel Disease and Healthy Older Adults for Whom Immunization Is Recommended
por: Caldera, Freddy, et al.
Publicado: (2022)

The impact of disease severity and duration on cost, early retirement and ability to work in rheumatoid arthritis in Europe: an economic modelling study
por: Galloway, James, et al.
Publicado: (2020)

Social Network Diversity and the Daily Burden of Inflammatory Bowel Disease
por: Greene-Higgs, LaVana, et al.
Publicado: (2023)

Toxoplasmosis Frequency Rate in Rheumatoid Arthritis Patients in Northeastern Iran
por: Zarean, Mehdi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_o1tde0bv7ocp8fj91vgk9q1rru